DJIA 17,191.37 -195.84 -1.13%
NASDAQ 4,637.99 -43.50 -0.93%
S&P 500 2,002.16 -27.39 -1.35%
market minute promo

Sarepta Therapeutics (NASDAQ: SRPT)



company name or ticker

Biotech Stock Mailbag: Prosensa, Sarepta, Arena Pharma, Hemispherx

5 Stocks To Consider When Playing Ebola

Sarepta Slumps as Eteplirsen NDA Submission Gets Delayed - Analyst Blog

Sarepta Slumps: SRPT Plunges 32.5% in Session - Tale of the Tape

Benzinga's Top Downgrades

Baird Downgrades Sarepta Therapeutics To Neutral

Fast Money Traders Discuss Merck, Garmin And Sarepta Therapeutics

Sarepta Therapeutics' (SRPT) CEO Chris Garabedian Hosts Regulatory Update on Eteplirsen Conference C

Sarepta Therapeutics' (SRPT) CEO Chris Garabedian Hosts Regulatory Update on Eteplirsen Conference Call (Transcript)

Sarepta Gets Delayed And The Stock Gets Drilled

Sector Update: Health Care Stocks Little Changed; Sarepta Therapeutics Slammed After FDA Asks for Mo

Sector Update: Health Care Stocks Little Changed; Sarepta Therapeutics Slammed After FDA Asks for More Data on Eteplirsen Drug Candidate
See More Articles...